Here, for the first time, our results demonstrate that CD44v4 is a major CD44 isoform expressed in metastatic breast cancer cells, and this CD44 variant is a membrane glycoprotein decorated with E-selectin binding sLex moieties. Here, CD44 is linked to breast carcinoma.